These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Interactions of an Anti-Sickling Drug with Hemoglobin in Red Blood Cells from a Patient with Sickle Cell Anemia. Strader MB; Liang H; Meng F; Harper J; Ostrowski DA; Henry ER; Shet AS; Eaton WA; Thein SL; Alayash AI Bioconjug Chem; 2019 Mar; 30(3):568-571. PubMed ID: 30794381 [TBL] [Abstract][Full Text] [Related]
7. Nitric oxide reduces sickle hemoglobin polymerization: potential role of nitric oxide-induced charge alteration in depolymerization. Ikuta T; Thatte HS; Tang JX; Mukerji I; Knee K; Bridges KR; Wang S; Montero-Huerta P; Joshi RM; Head CA Arch Biochem Biophys; 2011 Jun; 510(1):53-61. PubMed ID: 21457702 [TBL] [Abstract][Full Text] [Related]
8. MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease. Demers M; Sturtevant S; Guertin KR; Gupta D; Desai K; Vieira BF; Li W; Hicks A; Ismail A; Gonçalves BP; Di Caprio G; Schonbrun E; Hansen S; Musayev FN; Safo MK; Wood DK; Higgins JM; Light DR Blood Adv; 2021 Mar; 5(5):1388-1402. PubMed ID: 33661300 [TBL] [Abstract][Full Text] [Related]
9. Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds. Safo MK; Abdulmalik O; Danso-Danquah R; Burnett JC; Nokuri S; Joshi GS; Musayev FN; Asakura T; Abraham DJ J Med Chem; 2004 Sep; 47(19):4665-76. PubMed ID: 15341482 [TBL] [Abstract][Full Text] [Related]
10. Established and experimental treatments for sickle cell disease. De Franceschi L; Corrocher R Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275 [TBL] [Abstract][Full Text] [Related]
11. Fluorescence Lifetime Measurement of Prefibrillar Sickle Hemoglobin Oligomers as a Platform for Drug Discovery in Sickle Cell Disease. Vunnam N; Hansen S; Williams DC; Been MO; Lo CH; Pandey AK; Paulson CN; Rohde JA; Thomas DD; Sachs JN; Wood DK Biomacromolecules; 2022 Sep; 23(9):3822-3830. PubMed ID: 35944154 [TBL] [Abstract][Full Text] [Related]
12. Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease. Pagare PP; Ghatge MS; Musayev FN; Deshpande TM; Chen Q; Braxton C; Kim S; Venitz J; Zhang Y; Abdulmalik O; Safo MK Bioorg Med Chem; 2018 May; 26(9):2530-2538. PubMed ID: 29655608 [TBL] [Abstract][Full Text] [Related]
13. The delay time in sickle cell disease after 40 years: A paradigm assessed. Ferrone FA Am J Hematol; 2015 May; 90(5):438-45. PubMed ID: 25645011 [TBL] [Abstract][Full Text] [Related]
14. Rational Drug Design of Peptide-Based Therapies for Sickle Cell Disease. Olubiyi OO; Olagunju MO; Strodel B Molecules; 2019 Dec; 24(24):. PubMed ID: 31842406 [TBL] [Abstract][Full Text] [Related]
15. Quantitative prediction of erythrocyte sickling for the development of advanced sickle cell therapies. Lu L; Li Z; Li H; Li X; Vekilov PG; Karniadakis GE Sci Adv; 2019 Aug; 5(8):eaax3905. PubMed ID: 31457104 [TBL] [Abstract][Full Text] [Related]
16. Nitrite decreases sickle hemoglobin polymerization in vitro independently of methemoglobin formation. Almeida LEF; Smith ML; Kamimura S; Vogel S; de Souza Batista CM; Quezado ZMN Toxicol Appl Pharmacol; 2023 Aug; 473():116606. PubMed ID: 37336294 [TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-HMF for the Treatment of Sickle Cell Disease. Xu GG; Pagare PP; Ghatge MS; Safo RP; Gazi A; Chen Q; David T; Alabbas AB; Musayev FN; Venitz J; Zhang Y; Safo MK; Abdulmalik O Mol Pharm; 2017 Oct; 14(10):3499-3511. PubMed ID: 28858508 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agents. Omar AM; Mahran MA; Ghatge MS; Chowdhury N; Bamane FH; El-Araby ME; Abdulmalik O; Safo MK Org Biomol Chem; 2015 Jun; 13(22):6353-70. PubMed ID: 25974708 [TBL] [Abstract][Full Text] [Related]
19. On the Binding Free Energy and Molecular Origin of Sickle Cell Hemoglobin Aggregation. Galamba N; Pipolo S J Phys Chem B; 2018 Aug; 122(30):7475-7483. PubMed ID: 29995412 [TBL] [Abstract][Full Text] [Related]
20. New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo? Oder E; Safo MK; Abdulmalik O; Kato GJ Br J Haematol; 2016 Oct; 175(1):24-30. PubMed ID: 27605087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]